12 Best ADR Stocks To Invest In According to Analysts

Page 11 of 11

1. Novo Nordisk A/S (NYSE:NVO)

Upside Potential: 39.74%

Novo Nordisk A/S (NYSE:NVO) is a global healthcare company based in Denmark, specializing in diabetes care, obesity treatment, and hormone replacement therapies. The company is known for prescription medications such as insulin, GLP-1 receptor agonists, and obesity management drugs such as Wegovy and Ozempic.

In the first nine months of 2024, Novo Nordisk A/S (NYSE:NVO) achieved 24% sales growth and 22% operating profit growth from the previous year, driven by the rising demand for its GLP-1-based diabetic and obesity medicines. The company’s GLP-1 treatments have expanded to cover three times more patients compared to three years ago, with GLP-1 volume market share increasing to 65% in 3 years.

Novo Nordisk A/S (NYSE:NVO) is also focused on expanding its product offering and growing its market share through innovation. The company’s recent phase 1 clinical trial results for its new experimental obesity drug, Amycretin, have shown promising results, with a 13.1% average weight loss after 12 weeks. This achievement surpasses the efficacy of its existing weight-loss drug, Wegovy, and outperforms other experimental treatments in the market.

According to Artisan Partners, Novo Nordisk A/S (NYSE:NVO) has the best obesity/Type 2 diabetes pipeline in the industry, which bodes well for the company’s future growth prospects. As the company continues to innovate and expand its product offerings, it is likely to attract more patients and healthcare providers, driving revenue growth and solidifying its position as a leader in the diabetes care market.

While we acknowledge the potential of Novo Nordisk A/S (NYSE:NVO) to grow, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than NVO but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock.

Disclosure. None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and investors. Please subscribe to our daily free newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 11 of 11